Rwanda has reported its first two cases of mpox (previously known as monkeypox), initiating an enhanced epidemic response. This comes shortly after 25 cases were confirmed in the neighboring city of Goma in DR Congo.
Dr. Edson Rwagasore, the Division Manager of Public Health Surveillance and Emergency Preparedness and Response at the Rwanda Biomedical Center (RBC), assured that Rwanda is equipped to handle the outbreak, drawing on systems and experience from previous health crises like COVID-19.
Dr. Rwagasore emphasized the critical role of early detection and rapid response. He highlighted that Rwanda has trained multisectoral rapid response teams at both national and district levels. He also urged the public to take preventive measures, such as avoiding contact with those showing symptoms, practicing good hygiene, and seeking medical attention if symptoms arise.
Symptoms of mpox include rash, fever, sore throat, headache, muscle aches, back pain, fatigue, and swollen lymph nodes. The country is also using advanced testing methods, including genomic sequencing, to manage the situation effectively.
Public awareness campaigns are being launched to educate people on how to prevent and recognize the virus. Vaccines are available and recommended for close contacts of mpox cases and high-risk groups.
Dr. Rwagasore called for calm and emphasized that informed and collective action is crucial in controlling the outbreak.